Aarti Drugs LtdAarti Drugs Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This webpage of Aarti Drugs Ltd is prepared by All Street Sevva using leading Cognitive Robots. If you are employed by Aarti Drugs Ltd and you wish to use your ESG aseessment, please contact us. Jump to the end of this webpage for potential risks for Aarti Drugs Ltd based on industry, geography and size.

Aarti Drugs Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 1.6.

SDG Transparency Score for Aarti Drugs Ltd 

2.3

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Aarti Drugs Ltd 
2.0

Environmental

3.2

Social

1.6

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1512Sol Gel Technologies Ltd
2.4
Medium
1512Windtree Therapeutics Inc
2.4
Medium
1529Aarti Drugs Ltd
2.3
Medium
1529ANI Pharmaceuticals Inc
2.3
Medium
1529Angion Biomedica Corp
2.3
Medium
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Aarti Drugs Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Aarti Drugs Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Aarti Drugs Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Aarti Drugs Ltd offer flexible work?

LockedSign up for free to unlock

Does Aarti Drugs Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Aarti Drugs Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Aarti Drugs Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose water use targets?

LockedSign up for free to unlock

Does Aarti Drugs Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Aarti Drugs Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Aarti Drugs Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Aarti Drugs Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Aarti Drugs Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Aarti Drugs Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Aarti Drugs Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Aarti Drugs Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Aarti Drugs Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Aarti Drugs Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Aarti Drugs Ltd
These potential risks are based on the size, segment and geographies of the company.

Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate, bisphenol " C, bisphenol " C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further, it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Sorry!

Failed to process!